When AI designs a drug, who gets the credit?
MIT Tech ReviewPaywall
Read Full Article at MIT Tech Review →Ad Slot — In-Article (728x90)
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform.
This is a summary. For the full story, read the original article at MIT Tech Review.
Original source: MIT Tech Review